Nureca · NSE: NURECA · BSE: 543264

Q4 FY25 results · Jan–Mar 2025

Nureca reported revenue from operations of ₹31.74 crore (up 87.0% from Q4 FY24) and net profit of ₹2.47 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue from operations31.7416.97+87.0%26.46+19.9%
Other income1.99(1.26)Turned profit1.48+34.9%
Total income33.7315.71+114.7%27.94+20.7%
Profit before tax2.05(6.47)Turned profit(3.25)Turned profit
Net profit for the period2.47(4.15)Turned profit(2.80)Turned profit
EPS, basic (₹)2.47(4.15)Turned profit(2.80)Turned profit
Net margin (%)7.8-24.4-10.6
Standalone · ₹ crore
ItemQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue from operations31.7519.56+62.3%27.21+16.7%
Other income2.00(1.25)Turned profit1.52+31.6%
Total income33.7518.31+84.3%28.73+17.5%
Profit before tax1.50(6.74)Turned profit(3.85)Turned profit
Net profit for the period2.07(4.41)Turned profit(3.29)Turned profit
EPS, basic (₹)2.07(4.41)Turned profit(3.29)Turned profit
Net margin (%)6.5-22.6-12.1
Consolidated
Filed with BSE
06 May 2025, 19:13 IST
Board meeting
05 May 2025
Period
01 Jan 2025 to 31 Mar 2025
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
06 May 2025, 19:13 IST
Board meeting
05 May 2025
Period
01 Jan 2025 to 31 Mar 2025
Review status
Audited
Source
XBRL filing on BSE